---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-035939"
form_type: "8-K"
ticker: "CLDI"
cik: "0001855485"
company_name: "Calidi Biotherapeutics, Inc."
filed_at: "2024-09-12T23:59:59+00:00"
generated_at: "2026-05-31T05:17:43.902899+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Calidi Biotherapeutics posts presentation on antitumor virotherapies after RedChip webinar

## Summary
- Presentation titled 'Systemic and Localized Antitumor Virotherapies' referenced during September 11, 2024 RedChip webinar.
- Webinar webcast available on Company's website Events and Presentation page.
- No specific financial, clinical, or operational updates disclosed in the filing.

## SEC filing metadata
- accession: 0001493152-24-035939
- form_type: 8-K
- ticker: CLDI
- cik: 0001855485
- company_name: Calidi Biotherapeutics, Inc.
- filed_at: 2024-09-12T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1855485/000149315224035939/0001493152-24-035939-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1855485/000149315224035939/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-035939
- JSON: https://secwatch.observer/filing/0001493152-24-035939.json
- Plain text: https://secwatch.observer/filing/0001493152-24-035939.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.